The total return over the past 12 months is -92.70% vs. +16.94% for the S&P 500. So far it's up -60.23% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (92.70%) | (56.11%) | (68.35%) | (46.28%) | (44.03%) | N/A |
| Total Return CAGR | (92.70%) | (56.11%) | (68.35%) | (46.28%) | (44.03%) | N/A |
| Revenue CAGR | +287.31% | N/A | +11.63% | N/A | +10.57% | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
VistaGen Therapeutics, Inc. (VTGN)
| Year | Start price | End price | VTGN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.66 | $0.26 | (60.23%) | +14.51% | (74.74%) |
| 2025 | $2.95 | $0.66 | (77.56%) | +17.72% | (95.28%) |
| 2024 | $5.14 | $2.95 | (42.61%) | +24.89% | (67.50%) |
| 2023 | $3.00 | $5.14 | +71.33% | +26.19% | +45.14% |
| 2022 | $58.50 | $3.00 | (94.87%) | (18.17%) | (76.70%) |
| 2021 | $58.20 | $58.50 | +0.52% | +28.74% | (28.22%) |
| 2020 | $20.70 | $58.20 | +181.16% | +18.37% | +162.79% |
| 2019 | $45.00 | $20.70 | (54.00%) | +31.22% | (85.22%) |
| 2018 | $33.30 | $45.00 | +35.14% | (4.56%) | +39.70% |
| 2017 | $111.90 | $33.30 | (70.24%) | +21.70% | (91.94%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
